Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
Identifieur interne : 000017 ( Pmc/Checkpoint ); précédent : 000016; suivant : 000018Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
Auteurs : Emily C. O'Brien [États-Unis] ; Michael T. Durheim [États-Unis] ; Victoria Gamerman [États-Unis] ; Sandy Garfinkel [États-Unis] ; Kevin J. Anstrom [États-Unis] ; Scott M. Palmer [États-Unis] ; Craig S. Conoscenti [États-Unis]Source :
- BMJ Open Respiratory Research [ 2052-4439 ] ; 2016.
Abstract
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterised by progressive loss of lung function. Its clinical course is variable but ultimately fatal. There is a need for a multicentre patient registry incorporating longitudinal clinical data and biological samples to improve understanding of the natural history of IPF and contemporary practice patterns.
The Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry is a national IPF registry in the USA. This registry will enrol approximately 300 patients with newly diagnosed IPF over 2 years at approximately 14 tertiary pulmonary care sites. Participants will be followed for 3–5 years and will receive usual care, as defined by their physician. Clinical data from the year prior to diagnosis will be collected from medical record review on enrolment. Subsequently, data on diagnostic evaluations, pulmonary function tests, physical examinations, laboratory data and clinical events will be collected at routine clinical visits and via a call centre. Participants will complete patient-reported outcome questionnaires at enrolment and then at approximately 6-month intervals. Blood samples for cellular, genetic and transcriptomic analyses will be collected at the same intervals.
The first results from the IPF-PRO registry will be presented in 2015.
The IPF-PRO registry will improve understanding of the natural history of IPF, its impact on patients and current practice in the diagnosis and care of patients with IPF. The registry will establish a repository of biological samples from a well-characterised patient population for future research.
NCT01915511.
Url:
DOI: 10.1136/bmjresp-2015-000108
PubMed: 26835134
PubMed Central: 4716211
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:4716211Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry</title><author><name sortKey="O Brien, Emily C" sort="O Brien, Emily C" uniqKey="O Brien E" first="Emily C" last="O'Brien">Emily C. O'Brien</name><affiliation wicri:level="1"><nlm:aff id="af1"><addr-line>Department of Medicine</addr-line>,<institution>Duke University, Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Durheim, Michael T" sort="Durheim, Michael T" uniqKey="Durheim M" first="Michael T" last="Durheim">Michael T. Durheim</name><affiliation wicri:level="1"><nlm:aff id="af1"><addr-line>Department of Medicine</addr-line>,<institution>Duke University, Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Gamerman, Victoria" sort="Gamerman, Victoria" uniqKey="Gamerman V" first="Victoria" last="Gamerman">Victoria Gamerman</name><affiliation wicri:level="1"><nlm:aff id="af2"><addr-line>Biometrics and Data Management</addr-line>,<institution>Boehringer Ingelheim Pharmaceuticals Inc.</institution>,<addr-line>Ridgefield, Connecticut</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Garfinkel, Sandy" sort="Garfinkel, Sandy" uniqKey="Garfinkel S" first="Sandy" last="Garfinkel">Sandy Garfinkel</name><affiliation wicri:level="1"><nlm:aff id="af3"><addr-line>Clinical Operations</addr-line>,<institution>Boehringer Ingelheim Pharmaceuticals Inc.</institution>,<addr-line>Ridgefield, Connecticut</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Anstrom, Kevin J" sort="Anstrom, Kevin J" uniqKey="Anstrom K" first="Kevin J" last="Anstrom">Kevin J. Anstrom</name><affiliation wicri:level="1"><nlm:aff id="af4"><addr-line>Department of Biostatistics and Bioinformatics</addr-line>,<institution>Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Palmer, Scott M" sort="Palmer, Scott M" uniqKey="Palmer S" first="Scott M" last="Palmer">Scott M. Palmer</name><affiliation wicri:level="1"><nlm:aff id="af1"><addr-line>Department of Medicine</addr-line>,<institution>Duke University, Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Conoscenti, Craig S" sort="Conoscenti, Craig S" uniqKey="Conoscenti C" first="Craig S" last="Conoscenti">Craig S. Conoscenti</name><affiliation wicri:level="1"><nlm:aff id="af5"><addr-line>Clinical Development and Medical Affairs</addr-line>,<institution>Boehringer Ingelheim Pharmaceuticals Inc.</institution>,<addr-line>Ridgefield, Connecticut</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">26835134</idno><idno type="pmc">4716211</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716211</idno><idno type="RBID">PMC:4716211</idno><idno type="doi">10.1136/bmjresp-2015-000108</idno><date when="2016">2016</date><idno type="wicri:Area/Pmc/Corpus">000084</idno><idno type="wicri:Area/Pmc/Curation">000084</idno><idno type="wicri:Area/Pmc/Checkpoint">000017</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry</title><author><name sortKey="O Brien, Emily C" sort="O Brien, Emily C" uniqKey="O Brien E" first="Emily C" last="O'Brien">Emily C. O'Brien</name><affiliation wicri:level="1"><nlm:aff id="af1"><addr-line>Department of Medicine</addr-line>,<institution>Duke University, Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Durheim, Michael T" sort="Durheim, Michael T" uniqKey="Durheim M" first="Michael T" last="Durheim">Michael T. Durheim</name><affiliation wicri:level="1"><nlm:aff id="af1"><addr-line>Department of Medicine</addr-line>,<institution>Duke University, Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Gamerman, Victoria" sort="Gamerman, Victoria" uniqKey="Gamerman V" first="Victoria" last="Gamerman">Victoria Gamerman</name><affiliation wicri:level="1"><nlm:aff id="af2"><addr-line>Biometrics and Data Management</addr-line>,<institution>Boehringer Ingelheim Pharmaceuticals Inc.</institution>,<addr-line>Ridgefield, Connecticut</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Garfinkel, Sandy" sort="Garfinkel, Sandy" uniqKey="Garfinkel S" first="Sandy" last="Garfinkel">Sandy Garfinkel</name><affiliation wicri:level="1"><nlm:aff id="af3"><addr-line>Clinical Operations</addr-line>,<institution>Boehringer Ingelheim Pharmaceuticals Inc.</institution>,<addr-line>Ridgefield, Connecticut</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Anstrom, Kevin J" sort="Anstrom, Kevin J" uniqKey="Anstrom K" first="Kevin J" last="Anstrom">Kevin J. Anstrom</name><affiliation wicri:level="1"><nlm:aff id="af4"><addr-line>Department of Biostatistics and Bioinformatics</addr-line>,<institution>Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Palmer, Scott M" sort="Palmer, Scott M" uniqKey="Palmer S" first="Scott M" last="Palmer">Scott M. Palmer</name><affiliation wicri:level="1"><nlm:aff id="af1"><addr-line>Department of Medicine</addr-line>,<institution>Duke University, Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author><author><name sortKey="Conoscenti, Craig S" sort="Conoscenti, Craig S" uniqKey="Conoscenti C" first="Craig S" last="Conoscenti">Craig S. Conoscenti</name><affiliation wicri:level="1"><nlm:aff id="af5"><addr-line>Clinical Development and Medical Affairs</addr-line>,<institution>Boehringer Ingelheim Pharmaceuticals Inc.</institution>,<addr-line>Ridgefield, Connecticut</addr-line>,<country>USA</country></nlm:aff><country xml:lang="fr">États-Unis</country><wicri:regionArea># see nlm:aff country strict</wicri:regionArea></affiliation></author></analytic><series><title level="j">BMJ Open Respiratory Research</title><idno type="eISSN">2052-4439</idno><imprint><date when="2016">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><sec><title>Background</title><p>Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterised by progressive loss of lung function. Its clinical course is variable but ultimately fatal. There is a need for a multicentre patient registry incorporating longitudinal clinical data and biological samples to improve understanding of the natural history of IPF and contemporary practice patterns.</p></sec><sec><title>Methods/design</title><p>The Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry is a national IPF registry in the USA. This registry will enrol approximately 300 patients with newly diagnosed IPF over 2 years at approximately 14 tertiary pulmonary care sites. Participants will be followed for 3–5 years and will receive usual care, as defined by their physician. Clinical data from the year prior to diagnosis will be collected from medical record review on enrolment. Subsequently, data on diagnostic evaluations, pulmonary function tests, physical examinations, laboratory data and clinical events will be collected at routine clinical visits and via a call centre. Participants will complete patient-reported outcome questionnaires at enrolment and then at approximately 6-month intervals. Blood samples for cellular, genetic and transcriptomic analyses will be collected at the same intervals.</p></sec><sec><title>Results</title><p>The first results from the IPF-PRO registry will be presented in 2015.</p></sec><sec><title>Conclusions</title><p>The IPF-PRO registry will improve understanding of the natural history of IPF, its impact on patients and current practice in the diagnosis and care of patients with IPF. The registry will establish a repository of biological samples from a well-characterised patient population for future research.</p></sec><sec><title>Clinical trial number</title><p>NCT01915511.</p></sec></div></front><back><div1 type="bibliography"><listBibl><biblStruct><analytic><author><name sortKey="Raghu, G" uniqKey="Raghu G">G Raghu</name></author><author><name sortKey="Collard, Hr" uniqKey="Collard H">HR Collard</name></author><author><name sortKey="Egan, Jj" uniqKey="Egan J">JJ Egan</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nalysnyk, L" uniqKey="Nalysnyk L">L Nalysnyk</name></author><author><name sortKey="Cid Ruzafa, J" uniqKey="Cid Ruzafa J">J Cid-Ruzafa</name></author><author><name sortKey="Rotella, P" uniqKey="Rotella P">P Rotella</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Raghu, G" uniqKey="Raghu G">G Raghu</name></author><author><name sortKey="Chen, Sy" uniqKey="Chen S">SY Chen</name></author><author><name sortKey="Yeh, Ws" uniqKey="Yeh W">WS Yeh</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Richeldi, L" uniqKey="Richeldi L">L Richeldi</name></author><author><name sortKey="Du Bois, Rm" uniqKey="Du Bois R">RM du Bois</name></author><author><name sortKey="Raghu, G" uniqKey="Raghu G">G Raghu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="King, Te" uniqKey="King T">TE King</name></author><author><name sortKey="Bradford, Wz" uniqKey="Bradford W">WZ Bradford</name></author><author><name sortKey="Castro Bernardini, S" uniqKey="Castro Bernardini S">S Castro-Bernardini</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="King, Te" uniqKey="King T">TE King</name></author><author><name sortKey="Albera, C" uniqKey="Albera C">C Albera</name></author><author><name sortKey="Bradford, Wz" uniqKey="Bradford W">WZ Bradford</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Collard, Hr" uniqKey="Collard H">HR Collard</name></author><author><name sortKey="Tino, G" uniqKey="Tino G">G Tino</name></author><author><name sortKey="Noble, Pw" uniqKey="Noble P">PW Noble</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Schoenheit, G" uniqKey="Schoenheit G">G Schoenheit</name></author><author><name sortKey="Becattelli, I" uniqKey="Becattelli I">I Becattelli</name></author><author><name sortKey="Cohen, Ah" uniqKey="Cohen A">AH Cohen</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lamas, Dj" uniqKey="Lamas D">DJ Lamas</name></author><author><name sortKey="Kawut, Sm" uniqKey="Kawut S">SM Kawut</name></author><author><name sortKey="Bagiella, E" uniqKey="Bagiella E">E Bagiella</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ley, B" uniqKey="Ley B">B Ley</name></author><author><name sortKey="Collard, Hr" uniqKey="Collard H">HR Collard</name></author><author><name sortKey="King, Te" uniqKey="King T">TE King</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Martinez, Fj" uniqKey="Martinez F">FJ Martinez</name></author><author><name sortKey="Safrin, S" uniqKey="Safrin S">S Safrin</name></author><author><name sortKey="Weycker, D" uniqKey="Weycker D">D Weycker</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Mura, M" uniqKey="Mura M">M Mura</name></author><author><name sortKey="Porretta, Ma" uniqKey="Porretta M">MA Porretta</name></author><author><name sortKey="Bargagli, E" uniqKey="Bargagli E">E Bargagli</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Nathan, Sd" uniqKey="Nathan S">SD Nathan</name></author><author><name sortKey="Shlobin, Oa" uniqKey="Shlobin O">OA Shlobin</name></author><author><name sortKey="Weir, N" uniqKey="Weir N">N Weir</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Collard, Hr" uniqKey="Collard H">HR Collard</name></author><author><name sortKey="Moore, Bb" uniqKey="Moore B">BB Moore</name></author><author><name sortKey="Flaherty, Kr" uniqKey="Flaherty K">KR Flaherty</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Collard, Hr" uniqKey="Collard H">HR Collard</name></author><author><name sortKey="Yow, E" uniqKey="Yow E">E Yow</name></author><author><name sortKey="Richeldi, L" uniqKey="Richeldi L">L Richeldi</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Song, Jw" uniqKey="Song J">JW Song</name></author><author><name sortKey="Hong, Sb" uniqKey="Hong S">SB Hong</name></author><author><name sortKey="Lim, Cm" uniqKey="Lim C">CM Lim</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Dimmock, Aef" uniqKey="Dimmock A">AEF Dimmock</name></author><author><name sortKey="Chinchilli, Vm" uniqKey="Chinchilli V">VM Chinchilli</name></author><author><name sortKey="Criner, Gj" uniqKey="Criner G">GJ Criner</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Du Bois, Rm" uniqKey="Du Bois R">RM du Bois</name></author><author><name sortKey="Weycker, D" uniqKey="Weycker D">D Weycker</name></author><author><name sortKey="Albera, C" uniqKey="Albera C">C Albera</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ley, B" uniqKey="Ley B">B Ley</name></author><author><name sortKey="Ryerson, Cj" uniqKey="Ryerson C">CJ Ryerson</name></author><author><name sortKey="Vittinghoff, E" uniqKey="Vittinghoff E">E Vittinghoff</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Fingerlin, Te" uniqKey="Fingerlin T">TE Fingerlin</name></author><author><name sortKey="Murphy, E" uniqKey="Murphy E">E Murphy</name></author><author><name sortKey="Zhang, W" uniqKey="Zhang W">W Zhang</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Noth, I" uniqKey="Noth I">I Noth</name></author><author><name sortKey="Zhang, Y" uniqKey="Zhang Y">Y Zhang</name></author><author><name sortKey="Ma, Sf" uniqKey="Ma S">SF Ma</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Seibold, Ma" uniqKey="Seibold M">MA Seibold</name></author><author><name sortKey="Wise, Al" uniqKey="Wise A">AL Wise</name></author><author><name sortKey="Speer, Mc" uniqKey="Speer M">MC Speer</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Peljto, Al" uniqKey="Peljto A">AL Peljto</name></author><author><name sortKey="Zhang, Y" uniqKey="Zhang Y">Y Zhang</name></author><author><name sortKey="Fingerlin, Te" uniqKey="Fingerlin T">TE Fingerlin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ley, B" uniqKey="Ley B">B Ley</name></author><author><name sortKey="Brown, Kk" uniqKey="Brown K">KK Brown</name></author><author><name sortKey="Collard, Hr" uniqKey="Collard H">HR Collard</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Vij, R" uniqKey="Vij R">R Vij</name></author><author><name sortKey="Noth, I" uniqKey="Noth I">I Noth</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Belkin, A" uniqKey="Belkin A">A Belkin</name></author><author><name sortKey="Swigris, Jj" uniqKey="Swigris J">JJ Swigris</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swigris, Jj" uniqKey="Swigris J">JJ Swigris</name></author><author><name sortKey="Stewart, Al" uniqKey="Stewart A">AL Stewart</name></author><author><name sortKey="Gould, Mk" uniqKey="Gould M">MK Gould</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swigris, Jj" uniqKey="Swigris J">JJ Swigris</name></author><author><name sortKey="Brown, Kk" uniqKey="Brown K">KK Brown</name></author><author><name sortKey="Behr, J" uniqKey="Behr J">J Behr</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swigris, Jj" uniqKey="Swigris J">JJ Swigris</name></author><author><name sortKey="Fairclough, D" uniqKey="Fairclough D">D Fairclough</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Swigris, Jj" uniqKey="Swigris J">JJ Swigris</name></author><author><name sortKey="Esser, D" uniqKey="Esser D">D Esser</name></author><author><name sortKey="Conoscenti, Cs" uniqKey="Conoscenti C">CS Conoscenti</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Tomioka, H" uniqKey="Tomioka H">H Tomioka</name></author><author><name sortKey="Imanaka, K" uniqKey="Imanaka K">K Imanaka</name></author><author><name sortKey="Hashimoto, K" uniqKey="Hashimoto K">K Hashimoto</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ware, J" uniqKey="Ware J">J Ware</name></author><author><name sortKey="Kosinski, M" uniqKey="Kosinski M">M Kosinski</name></author><author><name sortKey="Keller, Sd" uniqKey="Keller S">SD Keller</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Rabin, R" uniqKey="Rabin R">R Rabin</name></author><author><name sortKey="De Charro, F" uniqKey="De Charro F">F de Charro</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Barr, Jt" uniqKey="Barr J">JT Barr</name></author><author><name sortKey="Schumacher, Ge" uniqKey="Schumacher G">GE Schumacher</name></author><author><name sortKey="Freeman, S" uniqKey="Freeman S">S Freeman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Jones, Pw" uniqKey="Jones P">PW Jones</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Crawford, B" uniqKey="Crawford B">B Crawford</name></author><author><name sortKey="Monz, B" uniqKey="Monz B">B Monz</name></author><author><name sortKey="Hohlfeld, J" uniqKey="Hohlfeld J">J Hohlfeld</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Gries, Ks" uniqKey="Gries K">KS Gries</name></author><author><name sortKey="Esser, D" uniqKey="Esser D">D Esser</name></author><author><name sortKey="Wiklund, I" uniqKey="Wiklund I">I Wiklund</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Austin, Pc" uniqKey="Austin P">PC Austin</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Kleinbaum, D" uniqKey="Kleinbaum D">D Kleinbaum</name></author><author><name sortKey="Kupper, Ll" uniqKey="Kupper L">LL Kupper</name></author><author><name sortKey="Nizam, A" uniqKey="Nizam A">A Nizam</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="King, Te" uniqKey="King T">TE King</name></author><author><name sortKey="Brown, Kk" uniqKey="Brown K">KK Brown</name></author><author><name sortKey="Raghu, G" uniqKey="Raghu G">G Raghu</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Martinez, Fj" uniqKey="Martinez F">FJ Martinez</name></author><author><name sortKey="De Andrade, Ja" uniqKey="De Andrade J">JA de Andrade</name></author><author><name sortKey="Anstrom, Kj" uniqKey="Anstrom K">KJ Anstrom</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Raghu, G" uniqKey="Raghu G">G Raghu</name></author><author><name sortKey="Million Rousseau, R" uniqKey="Million Rousseau R">R Million-Rousseau</name></author><author><name sortKey="Morganti, A" uniqKey="Morganti A">A Morganti</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Richeldi, L" uniqKey="Richeldi L">L Richeldi</name></author><author><name sortKey="Costabel, U" uniqKey="Costabel U">U Costabel</name></author><author><name sortKey="Selman, M" uniqKey="Selman M">M Selman</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Daniels, Ce" uniqKey="Daniels C">CE Daniels</name></author><author><name sortKey="Yi, Es" uniqKey="Yi E">ES Yi</name></author><author><name sortKey="Ryu, Jh" uniqKey="Ryu J">JH Ryu</name></author></analytic></biblStruct><biblStruct></biblStruct><biblStruct><analytic><author><name sortKey="White, Es" uniqKey="White E">ES White</name></author><author><name sortKey="Brown, Kk" uniqKey="Brown K">KK Brown</name></author><author><name sortKey="Collard, Hr" uniqKey="Collard H">HR Collard</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Lindell, Ko" uniqKey="Lindell K">KO Lindell</name></author><author><name sortKey="Black, Tr" uniqKey="Black T">TR Black</name></author><author><name sortKey="Hoffmann, K" uniqKey="Hoffmann K">K Hoffmann</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Moodley, Y" uniqKey="Moodley Y">Y Moodley</name></author><author><name sortKey="Goh, N" uniqKey="Goh N">N Goh</name></author><author><name sortKey="Glaspole, I" uniqKey="Glaspole I">I Glaspole</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Behr, J" uniqKey="Behr J">J Behr</name></author><author><name sortKey="Hoeper, Mm" uniqKey="Hoeper M">MM Hoeper</name></author><author><name sortKey="Kreuter, M" uniqKey="Kreuter M">M Kreuter</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Wuyts, W" uniqKey="Wuyts W">W Wuyts</name></author><author><name sortKey="Dahlqvist, C" uniqKey="Dahlqvist C">C Dahlqvist</name></author><author><name sortKey="Schlesser, M" uniqKey="Schlesser M">M Schlesser</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Ryerson, Cj" uniqKey="Ryerson C">CJ Ryerson</name></author><author><name sortKey="Tan, B" uniqKey="Tan B">B Tan</name></author><author><name sortKey="Fell, Cd" uniqKey="Fell C">CD Fell</name></author></analytic></biblStruct><biblStruct><analytic><author><name sortKey="Guenther, A" uniqKey="Guenther A">A Guenther</name></author></analytic></biblStruct><biblStruct></biblStruct></listBibl></div1></back></TEI><pmc article-type="research-article"><pmc-dir>properties open_access</pmc-dir>
<front><journal-meta><journal-id journal-id-type="nlm-ta">BMJ Open Respir Res</journal-id><journal-id journal-id-type="iso-abbrev">BMJ Open Respir Res</journal-id><journal-id journal-id-type="hwp">bmjresp</journal-id><journal-id journal-id-type="publisher-id">bmjopenrespres</journal-id><journal-title-group><journal-title>BMJ Open Respiratory Research</journal-title></journal-title-group><issn pub-type="epub">2052-4439</issn><publisher><publisher-name>BMJ Publishing Group</publisher-name><publisher-loc>BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26835134</article-id><article-id pub-id-type="pmc">4716211</article-id><article-id pub-id-type="publisher-id">bmjresp-2015-000108</article-id><article-id pub-id-type="doi">10.1136/bmjresp-2015-000108</article-id><article-categories><subj-group subj-group-type="heading"><subject>Interstitial Lung Disease</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1506</subject><subject>2220</subject></subj-group></article-categories><title-group><article-title>Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>O'Brien</surname><given-names>Emily C</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Durheim</surname><given-names>Michael T</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gamerman</surname><given-names>Victoria</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Garfinkel</surname><given-names>Sandy</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Anstrom</surname><given-names>Kevin J</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Palmer</surname><given-names>Scott M</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Conoscenti</surname><given-names>Craig S</given-names></name><xref ref-type="aff" rid="af5">5</xref></contrib></contrib-group><aff id="af1"><label>1</label><addr-line>Department of Medicine</addr-line>,<institution>Duke University, Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></aff><aff id="af2"><label>2</label><addr-line>Biometrics and Data Management</addr-line>,<institution>Boehringer Ingelheim Pharmaceuticals Inc.</institution>,<addr-line>Ridgefield, Connecticut</addr-line>,<country>USA</country></aff><aff id="af3"><label>3</label><addr-line>Clinical Operations</addr-line>,<institution>Boehringer Ingelheim Pharmaceuticals Inc.</institution>,<addr-line>Ridgefield, Connecticut</addr-line>,<country>USA</country></aff><aff id="af4"><label>4</label><addr-line>Department of Biostatistics and Bioinformatics</addr-line>,<institution>Duke Clinical Research Institute</institution>,<addr-line>Durham, North Carolina</addr-line>,<country>USA</country></aff><aff id="af5"><label>5</label><addr-line>Clinical Development and Medical Affairs</addr-line>,<institution>Boehringer Ingelheim Pharmaceuticals Inc.</institution>,<addr-line>Ridgefield, Connecticut</addr-line>,<country>USA</country></aff><author-notes><corresp><label>Correspondence to</label> Dr Emily C O'Brien; <email>emily.obrien@duke.edu</email></corresp></author-notes><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>11</day><month>1</month><year>2016</year></pub-date><volume>3</volume><issue>1</issue><elocation-id>e000108</elocation-id><history><date date-type="received"><day>3</day><month>9</month><year>2015</year></date><date date-type="rev-recd"><day>9</day><month>12</month><year>2015</year></date><date date-type="accepted"><day>12</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link></license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="bmjresp-2015-000108.pdf"></self-uri><abstract><sec><title>Background</title><p>Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease characterised by progressive loss of lung function. Its clinical course is variable but ultimately fatal. There is a need for a multicentre patient registry incorporating longitudinal clinical data and biological samples to improve understanding of the natural history of IPF and contemporary practice patterns.</p></sec><sec><title>Methods/design</title><p>The Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry is a national IPF registry in the USA. This registry will enrol approximately 300 patients with newly diagnosed IPF over 2 years at approximately 14 tertiary pulmonary care sites. Participants will be followed for 3–5 years and will receive usual care, as defined by their physician. Clinical data from the year prior to diagnosis will be collected from medical record review on enrolment. Subsequently, data on diagnostic evaluations, pulmonary function tests, physical examinations, laboratory data and clinical events will be collected at routine clinical visits and via a call centre. Participants will complete patient-reported outcome questionnaires at enrolment and then at approximately 6-month intervals. Blood samples for cellular, genetic and transcriptomic analyses will be collected at the same intervals.</p></sec><sec><title>Results</title><p>The first results from the IPF-PRO registry will be presented in 2015.</p></sec><sec><title>Conclusions</title><p>The IPF-PRO registry will improve understanding of the natural history of IPF, its impact on patients and current practice in the diagnosis and care of patients with IPF. The registry will establish a repository of biological samples from a well-characterised patient population for future research.</p></sec><sec><title>Clinical trial number</title><p>NCT01915511.</p></sec></abstract><kwd-group><kwd>Interstitial Fibrosis</kwd><kwd>Rare lung diseases</kwd></kwd-group></article-meta></front></pmc><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="O Brien, Emily C" sort="O Brien, Emily C" uniqKey="O Brien E" first="Emily C" last="O'Brien">Emily C. O'Brien</name></noRegion><name sortKey="Anstrom, Kevin J" sort="Anstrom, Kevin J" uniqKey="Anstrom K" first="Kevin J" last="Anstrom">Kevin J. Anstrom</name><name sortKey="Conoscenti, Craig S" sort="Conoscenti, Craig S" uniqKey="Conoscenti C" first="Craig S" last="Conoscenti">Craig S. Conoscenti</name><name sortKey="Durheim, Michael T" sort="Durheim, Michael T" uniqKey="Durheim M" first="Michael T" last="Durheim">Michael T. Durheim</name><name sortKey="Gamerman, Victoria" sort="Gamerman, Victoria" uniqKey="Gamerman V" first="Victoria" last="Gamerman">Victoria Gamerman</name><name sortKey="Garfinkel, Sandy" sort="Garfinkel, Sandy" uniqKey="Garfinkel S" first="Sandy" last="Garfinkel">Sandy Garfinkel</name><name sortKey="Palmer, Scott M" sort="Palmer, Scott M" uniqKey="Palmer S" first="Scott M" last="Palmer">Scott M. Palmer</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Belgique/explor/OpenAccessBelV2/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000017 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000017 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Belgique
|area= OpenAccessBelV2
|flux= Pmc
|étape= Checkpoint
|type= RBID
|clé= PMC:4716211
|texte= Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:26835134" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a OpenAccessBelV2
| This area was generated with Dilib version V0.6.25. |  |